William Blair Investment Management LLC bought a new stake in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 6,458 shares of the biotechnology company’s stock, valued at approximately $2,729,000.
Other institutional investors and hedge funds have also modified their holdings of the company. M & L Capital Management Ltd purchased a new position in Axon Enterprise in the 3rd quarter valued at about $30,000. Keating Financial Advisory Services Inc. purchased a new stake in Axon Enterprise during the 2nd quarter worth approximately $31,000. Wealth Enhancement Trust Services Inc. purchased a new stake in Axon Enterprise during the 3rd quarter worth approximately $33,000. Putney Financial Group LLC acquired a new position in shares of Axon Enterprise during the third quarter valued at approximately $36,000. Finally, Washington Trust Advisors Inc. raised its holdings in shares of Axon Enterprise by 1,300.0% during the second quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock valued at $39,000 after acquiring an additional 65 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.
Wall Street Analyst Weigh In
AXON has been the topic of a number of research analyst reports. Morgan Stanley lifted their price target on Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Piper Sandler reiterated an “overweight” rating and set a $540.00 price target (down from $561.00) on shares of Axon Enterprise in a research report on Friday, November 6th. Citigroup reissued a “market outperform” rating on shares of Axon Enterprise in a research note on Monday, November 2nd. Argus increased their price objective on Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, September 3rd. Finally, Raymond James Financial set a $675.00 price objective on Axon Enterprise in a report on Thursday, October 15th. Thirteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $612.18.
Read Our Latest Analysis on Axon Enterprise
Axon Enterprise Stock Down 2.9%
Shares of NASDAQ AXON opened at $306.44 on Tuesday. Axon Enterprise, Inc has a 12-month low of $291.45 and a 12-month high of $665.07. The stock has a market cap of $24.95 billion, a PE ratio of 98.22, a P/E/G ratio of 5.84 and a beta of 1.48. The company has a current ratio of 3.00, a quick ratio of 2.60 and a debt-to-equity ratio of 0.76. The company has a 50-day moving average of $413.60 and a 200 day moving average of $466.47.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The business had revenue of $908.55 million during the quarter, compared to analyst estimates of $934.33 million. During the same quarter in the previous year, the company posted $1.17 EPS. The firm’s revenue was up 27.8% on a year-over-year basis. As a group, sell-side analysts predict that Axon Enterprise, Inc will post 2.10 EPS for the current fiscal year.
Insider Buying and Selling
In other news, insider Isaiah Fields sold 1,017 shares of the business’s stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $480.45, for a total transaction of $488,617.65. Following the transaction, the insider directly owned 56,264 shares in the company, valued at $27,032,038.80. The trade was a 1.78% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey Kunins sold 9,605 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $626.70, for a total value of $6,019,453.50. Following the completion of the sale, the insider owned 97,761 shares of the company’s stock, valued at $61,266,818.70. This trade represents a 8.95% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 37,397 shares of company stock valued at $21,234,034. 4.20% of the stock is currently owned by company insiders.
About Axon Enterprise
Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.
See Also
- Five stocks we like better than Axon Enterprise
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
